Since its opening in 2015, the House of BioHealth has become a hub for biotech and digital health technology companies in Luxembourg. The facility is based on a cooperation between the Ministry of the Economy, private investors and the inter-municipal association in charge of the economic activity zone in Ehlerange. Its premises, now made up of 9,500 m2 of laboratories and 5.500 m2 of office space, help companies quickly become operational in terms of their R&D activities.
Lab and office space for biotech and healthtech companies
The House of BioHealth hosts healthtech companies – in particular SMEs – as well as certain activities of the Luxembourg Institute of Health (LIH) and the Luxembourg Centre for Systems Biomedicine (LCSB). In total, around 450 people work in the facility. A bioincubator offer close to 350 m2 of lab space available to receive healthtech spin-offs and start-ups.
The third extension of the House of BioHealth was inaugurated in the presence of H.R.H Crown Prince Guillaume. At the inauguration, medical refrigeration specialist B Medical Systems announced that it will open additional offices there. Negotiations are also ongoing with other companies wishing to benefit from its lab space.
I’m convinced that this is just a stepping stone towards a new era in the health sector.
“With research as the starting point, we have been able to include both healthcare and the private sector in this flagship project, the Luxembourg House of BioHealth,” said Deputy Prime Minister and Minister of Health Paulette Lenert. “I’m convinced that this is just a stepping stone towards a new era in the health sector.”
Next step: HE:AL Campus
“From the outset, the construction of the House of Biohealth has played a leading role in the development of the health technology sector, which is one of the pillars of our economic diversification,” said Minister of the Economy Franz Fayot. “It has made it possible to attract many renowned players and ensure sustainable development of the sector. The creation of the HE:AL Campus is the next key step to sustaining the success of the sector in the long term.”
The creation of the HE:AL Campus is the next key step to sustaining the success of the sector in the long term.
Announced in early 2022, the forthcoming Health And Life science Innovation (HE:AL) Campus will be dedicated to digital health and personalised medicine. It will primarily target companies active in the fields of medical devices, in vitro diagnostics, and digital health tools and services. It will also be open to R&D, innovation and production activities, as well as to health technologies consulting and services.
Complementary to the House of BioHealth, this large-scale infrastructure project, potentially comprising more than 50,000 m2 of buildable area, aims not only to complete existing healthtech accommodation infrastructures, but also to provide a conducive environment for the development of an innovative healthtech community.
Company support measures
Minister Fayot also announced the launch of a new performance programme, Fit 4 Innovation – HealthTech Market, which will be implemented by national innovation agency Luxinnovation during the first quarter of 2023. The aim of this programme is to help healthtech companies define their regulatory roadmap to obtain CE marking for their new and innovative medical devices and thus accelerate their launch on the European market.
In addition, the Ministry of the Economy, the National Research Fund and Luxinnovation have decided to join forces again to open a second Joint Call for HealthTech Projects aimed at building partnerships between companies, research and healthcare organisations. This includes matching HealthTech products or services at prototype stage with research and healthcare expertise to co-develop and validate these solutions at a clinical level for the benefit of patients and deliver leading innovation. The new call will open on 1 February 2023.